Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dl-dopa Methyl Ester
2. Dopa Methyl Ester, (d)-isomer
3. L-dopa Methyl Ester
4. Levodopa Methyl Ester
5. Levodopa Methyl Ester Hydrochloride
6. Levodopa Methyl Ester Hydrochloride, (dl)-isomer
7. Melevodopa
8. Methyl L-dopa
1. 1421-65-4
2. L-3,4-dihydroxyphenylalanine Methyl Ester Hydrochloride
3. Melevodopa Hydrochloride
4. Methyl L-dopa Hydrochloride
5. L-dopa Methyl Ester Hydrochloride
6. Levodopa Methyl Ester Hydrochloride
7. L-tyrosine, 3-hydroxy-, Methyl Ester, Hydrochloride
8. L-dopa Me Ester Hydrochloride
9. L-tyrosine, 3-hydroxy-, Methyl Ester, Hydrochloride (1:1)
10. Mfcd00038958
11. Alanine, 3-(3,4-dihydroxyphenyl)-, Methyl Ester, Hydrochloride, L-
12. St 41769
13. St-41769
14. Jfu1a8866v
15. 3,4-dihydroxyphenyl-l-alanine Methyl Ester Hydrochloride
16. Methyl L-3-(3,4-dihydroxyphenyl)alaninate Hydrochloride
17. Ncgc00093792-01
18. Alanine, 3-(3,4-dihydroxyphenyl)-, Methyl Ester, Hydrochloride
19. L-3,4-dihydroxyphenylalanine Methyl Ester Hcl
20. Dsstox_cid_25763
21. Dsstox_rid_81105
22. Dsstox_gsid_45763
23. 3,4-dihydroxy-l-phenylalanine Methyl Ester Hydrochloride
24. Methyl (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoate;hydrochloride
25. Cas-1421-65-4
26. Unii-jfu1a8866v
27. Nsc-295453
28. Mls002153271
29. Schembl453411
30. Chembl1255756
31. Dtxsid4045763
32. Act09358
33. Amy31294
34. Tox21_111221
35. Tox21_500356
36. H-phe{3,4-(oh)2}-ome.hcl
37. L-dopa Methyl Ester (hydrochloride)
38. Akos015912904
39. Tox21_111221_1
40. Ccg-221660
41. Cs-w012679
42. Lp00356
43. Nsc 295453
44. Ncgc00162132-03
45. Ncgc00261041-01
46. As-10467
47. Smr001230709
48. Eu-0100356
49. D 1507
50. I10411
51. L-3,4-dihydroxyphenylalanine Benzyl Ester
52. Sr-01000075804
53. J-007612
54. Sr-01000075804-1
55. Q27281493
56. 3-(3,4-dihydroxyphenyl)-l-alanine Methyl Ester Hydrochloride
57. L-3,4-dihydroxyphenylalanine Methyl Ester Hydrochloride, Solid
58. Methyl (s)-2-amino-3-(3,4-dihydroxyphenyl)propanoate Hydrochloride
| Molecular Weight | 247.67 g/mol |
|---|---|
| Molecular Formula | C10H14ClNO4 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 247.0611356 g/mol |
| Monoisotopic Mass | 247.0611356 g/mol |
| Topological Polar Surface Area | 92.8 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 222 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Global Sales Information
ABOUT THIS PAGE
A CAS-1421-65-4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-1421-65-4, including repackagers and relabelers. The FDA regulates CAS-1421-65-4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-1421-65-4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-1421-65-4 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-1421-65-4 supplier is an individual or a company that provides CAS-1421-65-4 active pharmaceutical ingredient (API) or CAS-1421-65-4 finished formulations upon request. The CAS-1421-65-4 suppliers may include CAS-1421-65-4 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-1421-65-4 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CAS-1421-65-4 DMF (Drug Master File) is a document detailing the whole manufacturing process of CAS-1421-65-4 active pharmaceutical ingredient (API) in detail. Different forms of CAS-1421-65-4 DMFs exist exist since differing nations have different regulations, such as CAS-1421-65-4 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CAS-1421-65-4 DMF submitted to regulatory agencies in the US is known as a USDMF. CAS-1421-65-4 USDMF includes data on CAS-1421-65-4's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CAS-1421-65-4 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CAS-1421-65-4 suppliers with USDMF on PharmaCompass.
CAS-1421-65-4 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-1421-65-4 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-1421-65-4 GMP manufacturer or CAS-1421-65-4 GMP API supplier for your needs.
A CAS-1421-65-4 CoA (Certificate of Analysis) is a formal document that attests to CAS-1421-65-4's compliance with CAS-1421-65-4 specifications and serves as a tool for batch-level quality control.
CAS-1421-65-4 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-1421-65-4 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-1421-65-4 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-1421-65-4 EP), CAS-1421-65-4 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-1421-65-4 USP).
LOOKING FOR A SUPPLIER?
